Phreesia, Inc. (NYSE:PHR) Insider Janet Gunzburg Sells 912 Shares

Phreesia, Inc. (NYSE:PHR) insider Janet Gunzburg sold 912 shares of the business’s stock in a transaction that occurred on Thursday, April 18th. The shares were sold at an average price of $22.85, for a total value of $20,839.20. Following the completion of the sale, the insider now owns 35,220 shares of the company’s stock, valued at approximately $804,777. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Janet Gunzburg also recently made the following trade(s):

• On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The shares were sold at an average price of $23.10, for a total value of $63,940.80.
• On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total transaction of $38,657.58.
• On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
• On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The stock was sold at an average price of $28.00, for a total transaction of $13,440.00.
• On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total transaction of $8,524.72.

Phreesia Trading Down 4.2 %

Shares of PHR traded down $0.95 during mid-day trading on Friday, reaching $21.67. The stock had a trading volume of 540,826 shares, compared to its average volume of 521,631. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78. The business’s fifty day moving average is $24.40 and its 200 day moving average is $21.26. Phreesia, Inc. has a 52-week low of $12.05 and a 52-week high of $34.98. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -8.98 and a beta of 0.92.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter in the previous year, the company earned ($0.72) EPS. The business’s revenue for the quarter was up 24.0% compared to the same quarter last year. On average, sell-side analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on PHR shares. Robert W. Baird boosted their price objective on shares of Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, March 18th. Stephens reissued an “overweight” rating and issued a $28.00 price objective on shares of Phreesia in a report on Friday, March 22nd. Canaccord Genuity Group upped their target price on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, March 15th. Finally, Truist Financial assumed coverage on shares of Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $31.62.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. International Assets Investment Management LLC raised its stake in shares of Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares during the period. Captrust Financial Advisors increased its holdings in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after purchasing an additional 866 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Phreesia in the first quarter valued at approximately $43,000. State of Wyoming lifted its stake in Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after purchasing an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Phreesia by 85.4% in the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after buying an additional 1,445 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.